Veeva Systems (VEEV) stock
Last close $266.22 on 2026-11-20 (+1.26%) · Sector: Healthcare
Veeva Systems sells cloud-based software to life sciences companies, such as drug and medical device makers, to help them manage their work and data. It mainly earns money through recurring subscription and service fees from these customers.
Veeva's revenue and profit have grown steadily over the past eight quarters, and its balance sheet is strong with no long-term debt reported. Over the past year the stock returned 12.9%, beating the S&P 500's 3.2%, but it sits 18.3% below its 52-week high and swings far more than the market. Insiders sold about $6.2 million of stock in the last 90 days and made no purchases. Shares rose the day after 3 of the 4 recent earnings reports.
Key numbers
- Market cap: $43.9B
- Revenue (last 12 months): $3.46B
- Revenue growth: +16.5%
- Gross margin: 75.0%
- Operating margin: 30.1%
- P/E: 43.6
- P/S: 12.7
- Debt to equity: 0.00
- Current ratio: 5.45
Quality score
Overall 50/100 · growth 43 · profitability 56 · financial health 92 · value 7
Performance and risk
1-year return +12.9% vs S&P 500 +3.1% · volatility 42.4% (S&P 500 14.2%) · largest drop -37.5% · beta 0.55
Stock move the day after earnings
- 2026-03-04: +4.0%
- 2026-06-03: -0.1%
- 2026-08-26: +15.2%
- 2026-11-06: +0.9%
Insider trades (12 months)
Bought $0.0M · sold $16.8M
VEEV stock research · VEEV options calculator · Stocks to buy, hold or sell today
StrikeWright provides AI signals only, not financial advice.